Oculus
Innovative Sciences Inc. (Nasdaq: OCLS) received a new U. S. patent for the
use of Microcyn(R) Technology hypochlorous acid in the treatment and
mitigation of atopic dermatitis. The stock price rose 14 cents to $1.64
Oculus Innovative receives new patent
July 08, 2015 at 13:22 PM EDT
